NEW YORK (Reuters Health) – Patients with Kawasaki disease that is likely to be refractory, based on a standardized scoring system, respond well to primary treatment with a combination of intravenous immune globulin (IVIG) and pulsed IV methylprednisolone (IVMP), a Japanese team reports in Pediatrics for...